Search Within

Hematology-Oncology Fellows

Formats
  1. Meeting Abstract (2134)
  2. Journal Article (1757)
  3. Review (262)
  4. Editorial (133)
  5. Research Letter (85)
  6. Correspondence (45)
  7. Book Section (31)
  8. Guidelines (25)
  9. Miscellaneous (13)
  10. Conference Paper (8)
Groups
  1. Department of Medicine (4174)
  2. Weinberg Fellows (2757)
  3. Hematologic Malignancies, Division of (2493)
  4. Solid Tumor Oncology Division (2423)
  5. Center for Hematologic Malignancies (1945)
  6. GSK Faculty (1879)

More Groups

People
  1. Sergio Giralt (433)
  2. Michael Scordo (389)
  3. Gunjan Shah (348)
  4. Miguel-Angel Perales (338)
  5. Sean Devlin (289)
  6. Marcel Van Den Brink (263)

More People

Years
  1. 2025 (345)
  2. 2024 (636)
  3. 2023 (600)
  4. 2022 (628)
  5. 2021 (503)
  6. 2020 (496)

More Years

Publications
  1. Blood (713)
  2. Journal of Clinical Oncology (685)
  3. Annals of Oncology (133)
  4. Clinical Cancer Research (131)
  5. Cancer Research (126)
  6. Biology of Blood and Marrow Transplantation (124)

More Publications

Publishers
  1. American Society of Hematology (806)
  2. American Society of Clinical Oncology (774)
  3. Elsevier Inc. (544)
  4. Nature Publishing Group (358)
  5. American Association for Cancer Research (352)
  6. Oxford University Press (211)

More Publishers

Results (4493)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Sonic Hedgehog pathway inhibitors: From clinical trials to clinical practice
    Research Letter

    Yan, B. Y.; Hibler, B. P.; Menge, T.; Dunn, L.; Ho, A. L.; Rossi, A. M.
    British Journal of Dermatology (2019)

    Fulltext@MSK | Save
  • Patient-reported outcomes with chimeric antigen receptor T cell therapy: Challenges and opportunities
    Review

    Chakraborty, R.; Sidana, S.; Shah, G. L.; Scordo, M.; Hamilton, B. K.; Majhail, N. S.
    Biology of Blood and Marrow Transplantation (2019)

    Fulltext@MSK | Save
  • Peripheral circulating tumor DNA detection predicts poor outcomes after liver resection for metastatic colorectal cancer
    Journal Article

    Narayan, R. R.; Goldman, D. A.; Gonen, M.; Reichel, J.; Huberman, K. H.; Raj, S.; Viale, A.; Kemeny, N. E.; Allen, P. J.; Balachandran, V. P.; more...
    Annals of Surgical Oncology (2019)

    Fulltext@MSK | Save
  • Single agents vs combination chemotherapy in relapsed and refractory peripheral T-cell lymphoma: Results from the comprehensive oncology measures for peripheral T-cell lymphoma treatment (COMPLETE) registry
    Journal Article

    Stuver, R. N.; Khan, N.; Schwartz, M.; Acosta, M.; Federico, M.; Gisselbrecht, C.; Horwitz, S. M.; Lansigan, F.; Pinter-Brown, L. C.; Pro, B.; more...
    American Journal of Hematology (2019)

    Fulltext@MSK | Save
  • Corrupted coordination of epigenetic modifications leads to diverging chromatin states and transcriptional heterogeneity in CLL
    Journal Article

    Pastore, A.; Gaiti, F.; Lu, S. X.; Brand, R. M.; Kulm, S.; Chaligne, R.; Gu, H.; Huang, K. Y.; Stamenova, E. K.; Béguelin, W.; more...
    Nature Communications (2019)

    Fulltext@MSK | Save
  • Maximizing response: A case report of salvage chemotherapy after immune checkpoint inhibition in a patient with previous chemo-refractory metastatic esophageal carcinoma
    Journal Article

    Greally, M.; Agarwal, R.; El Dika, I.; Shamseddine, A.; El-Olayan, A.; Haibe, Y.; Paroder, V.; Shia, J.; Abou-Alfa, G. K.; Ku, G. Y.
    Journal of Gastrointestinal Oncology (2019)

    Fulltext@MSK | Save
  • Cyclin e mRNA: Assessing cyclin-dependent kinase (CDK) activation state to elucidate breast cancer resistance to CDK4/6 Inhibitors
    Editorial

    Chandarlapaty, S.; Razavi, P.
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Differential immune profiles distinguish the mutational subtypes of gastrointestinal stromal tumor
    Journal Article

    Vitiello, G. A.; Bowler, T. G.; Liu, M.; Medina, B. D.; Zhang, J. Q.; Param, N. J.; Loo, J. K.; Goldfeder, R. L.; Chibon, F.; Rossi, F.; more...
    Journal of Clinical Investigation (2019)

    Fulltext@MSK | Save
  • Targeted APC activation in cancer immunotherapy to enhance the abscopal effect
    Review

    Suek, N.; Campesato, L. F.; Merghoub, T.; Khalil, D. N.
    Frontiers in Immunology (2019)

    Fulltext@MSK | Save
  • Outcomes of patients with metastatic clear-cell renal cell carcinoma treated with second-line VEGFR-TKI after first-line immune checkpoint inhibitors
    Journal Article

    Shah, A. Y.; Kotecha, R. R.; Lemke, E. A.; Chandramohan, A.; Chaim, J. L.; Msaouel, P.; Xiao, L.; Gao, J.; Campbell, M. T.; Zurita, A. J.; more...
    European Journal of Cancer (2019)

    Fulltext@MSK | Save